Novolog (Pharm-Up 1966) Ltd (TLV:NVLG)
Israel · Delayed Price · Currency is ILS · Price in ILA 79.90
-6.70 (-7.74%)
Jun 8, 2026, 5:24 PM IDT
Novolog (Pharm-Up 1966) Ratios and Metrics
Market cap in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 408 | 642 | 925 | 726 | 1,409 | 1,504 | |
Market Cap Growth | -48.05% | -30.63% | 27.45% | -48.50% | -6.30% | 5.66% |
Enterprise Value | 431 | 641 | 904 | 674 | 1,470 | 1,449 |
Last Close Price | 0.80 | 1.26 | 1.76 | 1.32 | 2.52 | 2.65 |
PE Ratio | 115.16 | 155.93 | 23.39 | - | 29.66 | 35.53 |
Forward PE | - | 14.02 | 14.02 | 14.02 | 14.02 | 14.02 |
PS Ratio | 0.23 | 0.36 | 0.46 | 0.44 | 0.93 | 1.20 |
PB Ratio | 1.11 | 1.74 | 2.42 | 1.83 | 3.03 | 3.50 |
P/TBV Ratio | 13.02 | 19.80 | 17.47 | 10.37 | 13.19 | 9.06 |
P/FCF Ratio | 2.67 | - | 6.37 | 4.43 | 16.07 | 28.51 |
P/OCF Ratio | 2.39 | - | 5.84 | 3.63 | 10.62 | 18.03 |
EV/Sales Ratio | 0.24 | 0.36 | 0.45 | 0.41 | 0.98 | 1.15 |
EV/EBITDA Ratio | 4.01 | 8.29 | 8.65 | 4.98 | 14.40 | 15.81 |
EV/EBIT Ratio | 8.89 | 14.00 | 12.43 | 12.50 | 18.90 | 20.87 |
EV/FCF Ratio | 2.81 | - | 6.23 | 4.12 | 16.77 | 27.46 |
Debt / Equity Ratio | 0.48 | 0.50 | 0.52 | 0.54 | 0.46 | 0.39 |
Debt / EBITDA Ratio | 1.66 | 1.77 | 1.53 | 1.36 | 1.74 | 1.55 |
Debt / FCF Ratio | 1.15 | - | 1.37 | 1.31 | 2.43 | 3.16 |
Net Debt / Equity Ratio | 0.04 | 0.17 | -0.13 | -0.04 | 0.09 | -0.17 |
Net Debt / EBITDA Ratio | 0.16 | 0.80 | -0.47 | -0.13 | 0.39 | -0.78 |
Net Debt / FCF Ratio | 0.09 | -3.33 | -0.34 | -0.11 | 0.46 | -1.36 |
Asset Turnover | 0.65 | 0.70 | 0.69 | 0.63 | 0.64 | 0.56 |
Inventory Turnover | 4.74 | 5.83 | 6.53 | 6.74 | 7.07 | 4.97 |
Quick Ratio | 0.78 | 0.73 | 0.83 | 0.85 | 0.87 | 0.92 |
Current Ratio | 0.94 | 0.93 | 0.96 | 0.96 | 0.98 | 1.03 |
Return on Equity (ROE) | 0.93% | 1.20% | 10.54% | -9.15% | 11.38% | 12.35% |
Return on Assets (ROA) | 1.07% | 1.10% | 1.56% | 1.29% | 2.06% | 1.94% |
Return on Invested Capital (ROIC) | 9.68% | 7.89% | 14.53% | 12.23% | 13.53% | 16.38% |
Return on Capital Employed (ROCE) | 8.90% | 8.50% | 12.60% | 8.90% | 11.40% | 11.60% |
Earnings Yield | 0.87% | 0.64% | 4.28% | -5.79% | 3.37% | 2.81% |
FCF Yield | 37.52% | -2.88% | 15.69% | 22.57% | 6.22% | 3.51% |
Dividend Yield | 4.52% | 3.12% | 2.78% | 2.23% | 2.60% | 3.54% |
Payout Ratio | 564.17% | 486.03% | 101.17% | - | 67.14% | 75.62% |
Buyback Yield / Dilution | -0.02% | -0.02% | 0.04% | 0.94% | -0.14% | -9.08% |
Total Shareholder Return | 4.50% | 3.09% | 2.82% | 3.17% | 2.46% | -5.54% |